STEM CELLS AND HEPATOCARCINOGENESIS
干细胞与肝癌发生
基本信息
- 批准号:7625965
- 负责人:
- 金额:$ 25.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AFP geneAdenovirus VectorBiliaryBone MarrowBone Marrow CellsBone Marrow Stem CellBone Marrow TransplantationCell ProliferationCell fusionCellsCholine DeficiencyDevelopmentDiethylnitrosamineDuct (organ) structureDuctalEnzymesEthionineEtiologyExposure toFemaleFundingGoalsHepatocarcinogenesisHepatocyteInbred F344 RatsInjuryKnowledgeLabelLaboratoriesLesionLiverLiver Stem CellMalignant NeoplasmsMalignant neoplasm of liverModelingMusNeoplasm MetastasisNodulePathway interactionsPopulationPremalignantPrevention strategyPrimary carcinoma of the liver cellsProceduresProtocols documentationRattusResearch PersonnelSiteStem cellsStructureStudy modelsTestingTimeTissuesTransgenic OrganismsTreatment ProtocolsY Chromosomealcohol abuse therapyallyl alcoholcarcinogenesiscell typechemical carcinogenesismaleneoplasticoval cellprecursor cellprogramsreconstitution
项目摘要
Description (from applicant): One of the long standing unanswered questions in one of the most frequently studied models of carcinogenesis, chemical hepatocarcinogenesis, is what is the cell of origin of hepatocellular carcinomas (HCC)? The classic cellular pathway, championed by Emmanuel Farber, is that HCC develop from altered hepatocytes progressively through foci and preneoplastic nodules. However, studies on oval cells, which appear early during hepatocarcinogenesis, indicate that HCC may arise from "bipolar" liver progenitor cells located within terminal ducts or from pluripotent progenitor cells located adjacent to the ducts. In addition, recent studies on female mice and rats receiving bone marrow transplants from male donors indicated two possible origins of liver stem cells: from bipolar progenitor cells in the terminal ducts or from periductal stem cells. It is further postulated that these periductal progenitor cells may arise from circulating bone marrow stem cells either by differentiation into liver cells or that bone marrow cells may fuse with liver cells. In Specific Aim 1, the applicant proposes to develop a transgenic Fischer rat line expressing EGFP which can be used as a donor for bone marrow transplantation studies. In Specific Aim 2, three models of carcinogenesis: a. Continuous DEN, which features foci of altered hepatocytes preceding HCC with little or no oval cells will be used to determine if HCC arise from hepatocytes; b. Solt-Farber model, which features prominent proliferation of ductal oval cells to determine if HCC arise from bipolar ductal precursor cells; c. Choline-deficiency-ethionine, a model which features periductular proliferation of oval cells will be used to determine if preneoplastic lesions or HCC arise from periportal oval cells. In each of these protocols, DDPIV- (canalicular enzyme) female rats will receive a bone marrow transplant from DDPIV+, EGFP+, male donors. The origin of the populations of cells responding by proliferation will be identified by the presence of donor or recipient markers, and the types of cells identified through labeling with both liver lineage and littoral cell markers, when appropriate. In Specific Aim 3, the possibility of fusion of donor bone marrow stem cells with recipient liver cells will be tested and the possibility of fusion in etiology, progression or metastasis of HCC determined. Knowledge of the cellular origin of cancer is critical for understanding how cancer evolves and for developing prevention strategies.
描述(来自申请者):在最频繁研究的致癌模型之一--化学肝癌发生中,一个长期悬而未决的问题是,肝细胞癌的起源细胞是什么?Emmanuel Farber倡导的经典细胞途径是,肝细胞癌从改变的肝细胞逐渐发展到病灶和癌前结节。然而,对早期出现在肝癌发生过程中的卵圆细胞的研究表明,肝细胞癌可能起源于位于末端导管内的“两极”肝祖细胞或位于导管附近的多能前体细胞。此外,最近对接受男性捐赠者骨髓移植的雌性小鼠和大鼠的研究表明,肝干细胞有两种可能的来源:来自末端导管中的双极祖细胞或来自导管周围干细胞。进一步推测,这些导管周围祖细胞可能来源于循环中的骨髓干细胞,或者分化为肝细胞,或者骨髓细胞与肝细胞融合。在具体目标1中,申请人建议建立一种表达绿色荧光蛋白的转基因Fischer大鼠系,作为骨髓移植研究的供体。在具体目标2中,三种癌变模型:a.连续DEN,其特征是肝细胞癌之前的改变的肝细胞灶很少或没有卵圆形细胞,将被用来确定肝细胞癌是否起源于肝细胞;b.Solt-Farber模型,其特征是导管内卵圆形细胞的显著增殖,以确定肝癌是否起源于双极导管前体细胞;c.胆碱缺乏-乙硫氨酸模型,其特征是卵圆细胞在导管周围的增殖,将被用于确定癌前病变或肝癌是否起源于门静脉周卵圆细胞。在每一种方案中,DDPIV-(管状酶)雌性大鼠将接受DDPIV+,EGFP+,男性捐赠者的骨髓移植。对增殖有反应的细胞群体的来源将通过供体或受体标记的存在以及适当时通过肝脏谱系和沿海细胞标记识别的细胞类型来确定。在具体目标3中,将测试供体骨髓干细胞与受体肝细胞融合的可能性,并确定在肝细胞癌的病因、进展或转移方面融合的可能性。了解癌症的细胞起源对于了解癌症如何演变和制定预防策略至关重要。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Infection, stem cells and cancer signals.
- DOI:10.2174/138920111794295675
- 发表时间:2011-02-01
- 期刊:
- 影响因子:2.8
- 作者:Sell S
- 通讯作者:Sell S
Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice.
肿瘤来源的间充质干细胞和原位位点增加了来自 MMTV-PyMT 小鼠的假定小鼠乳腺癌干细胞的肿瘤起始潜力。
- DOI:10.1007/s13277-012-0459-3
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Lanza,DeniseGrant;Ma,Jun;Guest,Ian;Uk-Lim,Chang;Glinskii,Anna;Glinsky,Gennadi;Sell,Stewart
- 通讯作者:Sell,Stewart
Corrigendum.
- DOI:10.1111/jebm.12410
- 发表时间:2020-08
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Preparation of epithelial and mesenchymal stem cells from murine mammary gland.
- DOI:10.1002/0471140856.tx2203s50
- 发表时间:2011-11-01
- 期刊:
- 影响因子:0
- 作者:Guest, Ian;Ilic, Zoran;Ma, Jun
- 通讯作者:Ma, Jun
Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet.
- DOI:10.1002/hep.23880
- 发表时间:2010-11
- 期刊:
- 影响因子:13.5
- 作者:Guest, Ian;Ilic, Zoran;Sell, Stewart
- 通讯作者:Sell, Stewart
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEWART SELL其他文献
STEWART SELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEWART SELL', 18)}}的其他基金
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8827703 - 财政年份:2012
- 资助金额:
$ 25.58万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
9031727 - 财政年份:2012
- 资助金额:
$ 25.58万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8629710 - 财政年份:2012
- 资助金额:
$ 25.58万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8293559 - 财政年份:2012
- 资助金额:
$ 25.58万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8464677 - 财政年份:2012
- 资助金额:
$ 25.58万 - 项目类别:
相似海外基金
Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
- 批准号:
19K09482 - 财政年份:2019
- 资助金额:
$ 25.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
- 批准号:
2273599 - 财政年份:2019
- 资助金额:
$ 25.58万 - 项目类别:
Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
- 批准号:
18K14964 - 财政年份:2018
- 资助金额:
$ 25.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
- 批准号:
16K18873 - 财政年份:2016
- 资助金额:
$ 25.58万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
- 批准号:
9193681 - 财政年份:2016
- 资助金额:
$ 25.58万 - 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
- 批准号:
15K18939 - 财政年份:2015
- 资助金额:
$ 25.58万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
- 批准号:
26450450 - 财政年份:2014
- 资助金额:
$ 25.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
- 批准号:
26462183 - 财政年份:2014
- 资助金额:
$ 25.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
- 批准号:
26893253 - 财政年份:2014
- 资助金额:
$ 25.58万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
- 批准号:
24701021 - 财政年份:2012
- 资助金额:
$ 25.58万 - 项目类别:
Grant-in-Aid for Young Scientists (B)